ZA695453B - Multivalent live vaccine - Google Patents

Multivalent live vaccine

Info

Publication number
ZA695453B
ZA695453B ZA695453*A ZA695453A ZA695453B ZA 695453 B ZA695453 B ZA 695453B ZA 695453 A ZA695453 A ZA 695453A ZA 695453 B ZA695453 B ZA 695453B
Authority
ZA
South Africa
Prior art keywords
live vaccine
multivalent live
multivalent
vaccine
live
Prior art date
Application number
ZA695453*A
Inventor
E Buynak
M Hilleman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA695453B publication Critical patent/ZA695453B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0015—Combination vaccines based on measles-mumps-rubella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA695453*A 1968-09-11 1969-07-29 Multivalent live vaccine ZA695453B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75923768A 1968-09-11 1968-09-11

Publications (1)

Publication Number Publication Date
ZA695453B true ZA695453B (en) 1971-03-31

Family

ID=25054907

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA695453*A ZA695453B (en) 1968-09-11 1969-07-29 Multivalent live vaccine

Country Status (10)

Country Link
AT (1) AT291440B (en)
BE (1) BE738674A (en)
BR (1) BR6912333D0 (en)
DE (1) DE1944956A1 (en)
ES (1) ES371256A1 (en)
FR (1) FR2017790A1 (en)
IE (1) IE33311B1 (en)
IL (1) IL32922A (en)
NL (1) NL6913032A (en)
ZA (1) ZA695453B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633518B1 (en) * 1988-06-30 1991-03-22 Merieux Inst METHOD FOR STABILIZING VACCINES AND ASSOCIATIONS OF ATTENUATED VIRUS VACCINES PRESERVED IN LYOPHILIZED FORM, AND COMPOSITIONS OBTAINED

Also Published As

Publication number Publication date
IE33311B1 (en) 1974-05-15
AT291440B (en) 1971-07-12
IE33311L (en) 1970-03-11
IL32922A0 (en) 1969-11-30
FR2017790A1 (en) 1970-05-22
IL32922A (en) 1973-01-30
DE1944956A1 (en) 1970-03-19
BE738674A (en) 1970-03-10
BR6912333D0 (en) 1973-04-12
ES371256A1 (en) 1972-04-01
NL6913032A (en) 1970-03-13

Similar Documents

Publication Publication Date Title
ZA705405B (en) Vaccines
MY7500028A (en) Bromo-ergocryptine
YU31734B (en) Drzac posrednickih elemenata u kotrljajnim lezistima
YU212769A (en) Kolutni filtar
ZA711382B (en) Poultry vaccine
YU193169A (en) Cipela
IE32701L (en) Pyridazones-herbicides
IL32325A0 (en) 1-halogen-1-formylcarbonyl-phenylhydrazones
CH499313A (en) Eye sunshade
MY7100026A (en) Dibenzocycloheptene derivatives
ZA695572B (en) Oral preparation
IL32922A0 (en) Multivalent live vaccine
IE35729B1 (en) Vaccine preparation
IL32962A (en) Vaccine preparations
GB1217190A (en) Hairpieces
IL36649A0 (en) Varicella vaccine
AU436707B2 (en) Multivalent vaccines
IL32875A (en) Oxazinobenzodiazepines
IL31653A (en) 18-nor-13beta-ethyl-5alpha-androstan-3-ones
IL35339A0 (en) Crossbar-distributor
ZA693919B (en) Animal vaccines and methods for using
AU6032669A (en) Multivalent vaccines
ZA706601B (en) Veterinary vaccine
CA798292A (en) Somatic antigen vaccines
IE33112B1 (en) Emulsifiers